JPM vs OCCI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
OCCI exhibits significant financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a catastrophic dividend payout ratio of 964.29%. While the stock appears cheap on a Price-to-Book (0.68) and Forward P/E (1.99) basis, these metrics are likely value traps given the negative ROE (-24.34%) and a persistent bearish technical trend. The company is currently paying out dividends far in excess of its earnings, which is unsustainable and suggests a looming dividend cut. Despite a positive ROA, the overall fundamental health is poor, and the price action confirms a long-term decline.
Compare Another Pair
Related Comparisons
JPM vs OCCI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and OFS Credit Company, Inc. (OCCI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.